Compiled for Mercy Manor from peer-reviewed research and the published guidance of NIDA, SAMHSA, and the American Medical Association’s JAMA. Every figure below is cited to a primary source.

The thirty-day myth

The twenty-eight-day treatment program is a cultural fixture. It is also, for many people, a mismatch to the problem — and the reason why is one of the most important findings in addiction medicine.

In 2000, a review in JAMA by A. Thomas McLellan and colleagues asked a simple question: if addiction is a real medical illness, what kind is it? They compared drug dependence to three chronic conditions everyone accepts as medical — type 2 diabetes, hypertension, and asthma — and found the resemblance striking. Genetic heritability, the role of personal behavior, the course of the illness, and, most tellingly, the relapse rates were all comparable. Between 40 and 60 percent of people treated for substance dependence return to use within a year — almost exactly the range for hypertension and asthma (50 to 70 percent) and overlapping diabetes (30 to 50 percent).1

No one treats diabetes with a single twenty-eight-day program and then withdraws all care and calls the later relapse a failure. Yet that is precisely how addiction has usually been treated.

McLellan's team made that point directly. Imagine, they wrote, applying the rehab model to high blood pressure: admit the patient to a twenty-eight-day hypertension program, counsel them on diet and exercise, discharge them with no ongoing medication or monitoring, and then, six months later, count as successes only those who stayed perfectly healthy the entire time on their own. It would be considered malpractice. For a chronic condition, relapse after the withdrawal of care is evidence that care was withdrawn too soon — not evidence that treatment doesn't work.1

The federal government's own guidance draws the practical conclusion. The National Institute on Drug Abuse, in its Principles of Drug Addiction Treatment, states plainly that most people need at least three months in treatment to meaningfully reduce drug use, that participation of less than 90 days is “of limited effectiveness,” and that longer durations are recommended to maintain gains.2 Ninety days is described there as a floor, not a target — the point below which treatment often can't get traction, not the point at which someone is finished.

Time is the active ingredient

If ninety days is the floor, what does more time buy? The research on treatment retention is some of the most consistent in the field. In the federally funded Drug Abuse Treatment Outcome Study — more than 10,000 people across 96 programs — those who stayed in long-term residential or outpatient treatment for at least 90 days had markedly better outcomes afterward than those who left earlier.3 A separate analysis of national treatment data found the same dose-response shape: the longer someone stayed, the greater the reduction in drug use.4

We should be careful here, because this is exactly the kind of claim that deserves scrutiny. People who stay in treatment longer may simply be more motivated to begin with, and motivation — not time — could be doing the work. Researchers know this confounder well and try to account for it, but observational data can never fully rule it out.4 So the honest statement is this: length of stay is one of the most reliable predictors of good outcomes, and there are strong reasons to think time itself is part of the cause, even if no study can prove the precise number of days.

Recovery is built, not dispensed

Why would time itself matter? The most useful answer comes from the concept of recovery capital — a framework developed by sociologists William Cloud and Robert Granfield to describe the sum of resources a person can draw on to get well and stay well. They identified four kinds: social capital (relationships, family, a sober community), physical capital (housing, income, safety, health), human capital (skills, education, employability, coping ability), and cultural capital (values, belonging, a sense of one's place in the world).5 Later research found that the amount of recovery capital a person has actually predicts whether their recovery lasts.6

Read that list again and notice something: not one of those resources can be handed to a woman at discharge. Every one has to be rebuilt, slowly. A relationship repaired. A job held. An apartment kept. A skill practiced until it's hers. This is the bridge between the abstract finding and the concrete design of a program — recovery capital is why time is the active ingredient. A month is not enough time to build a life. A year begins to be.

The strongest experimental evidence for this comes from recovery housing. In a randomized controlled trial published in the American Journal of Public Health, adults leaving inpatient treatment were assigned either to a communal recovery home or to usual aftercare. Two years later, the recovery-home group had dramatically better outcomes: substance use of 31 percent versus 65 percent, average monthly income of $989 versus $440, and an incarceration rate of 3 percent versus 9 percent.7 A companion cost analysis found the recovery-home condition produced a net benefit to society of roughly $29,000 per person over those two years, and that residents who stayed six months or longer reached 84 percent abstinence versus 54 percent for shorter stays.8 A broader systematic review in Psychiatric Services concluded that residential treatment shows real value and belongs among covered benefits — while honestly noting the evidence base is still heterogeneous and needs strengthening.9 In 2023, SAMHSA issued national best-practice guidance formally recognizing recovery housing as a support for sustained recovery.10

For a woman, the wound underneath

Everything so far is true for anyone. But Mercy Manor serves women, and for women the pathway into addiction and crisis is, far more often than not, a pathway out of something else.

The foundational evidence is the Adverse Childhood Experiences Study — a survey of more than 9,500 adults, published in 1998 by Vincent Felitti, Robert Anda, and colleagues. It found a graded, dose-response relationship between the number of categories of childhood adversity a person experienced — abuse, neglect, a household marked by violence, addiction, mental illness, or incarceration — and their risk, decades later, of addiction, depression, and suicide. A person with four or more such experiences had, among other elevated risks, roughly twelve times the odds of having attempted suicide compared to someone with none.11 A later study in Pediatrics traced the same pattern specifically into drug use, showing that childhood adversity sharply raised the likelihood of early initiation and later dependence.12

Two clarifications matter, because this data is often misused. First, these are population-level associations, not individual destinies — the researchers themselves are emphatic that a high score is a statement of risk, not a sentence, and that a single stable, caring relationship can buffer a child against much of the harm.13 Second, the point is not to explain away a woman's choices, but to understand the ground they were made on. Our fuller explainer on ACEs holds this line carefully.

What follows from that childhood is a well-documented adult pattern. A large majority of women in substance-use treatment have trauma histories, and a substantial share meet criteria for post-traumatic stress disorder — studies report trauma exposure in roughly 55 to 99 percent and PTSD in roughly 30 to 59 percent, depending on how each is defined.14 This is the clinical basis of the “self-medication” pathway: the substance is, at first, the thing that makes the unbearable bearable. Intimate partner violence compounds it in both directions — abuse raises the risk of substance use, substance use raises the risk of abuse, and ongoing violence predicts relapse and dropout from treatment.15

The clinical implication is direct and it is now the consensus of the field: treating the addiction while leaving the trauma unaddressed is a setup for relapse. The two have to be treated together.16

The standard of care has a name

“Treat them together, and treat them for women” is not a slogan; it is codified national guidance. Two frameworks define it.

The first is trauma-informed care. SAMHSA — the federal Substance Abuse and Mental Health Services Administration — defines a trauma-informed approach by four commitments (the “Four R's”): to realize how widespread trauma is, to recognize its signs, to respond by embedding that knowledge into every practice, and to actively resist re-traumatizing the people in one's care. It rests on six principles: safety; trustworthiness and transparency; peer support; collaboration; empowerment, voice, and choice; and attention to cultural, historical, and gender issues.17 A place that runs on those principles feels different to a frightened woman within the first hour — and that felt difference is the point.

The second is gender-responsive treatment. SAMHSA's clinical guidance for women's services (TIP 51) establishes that women do best in care that is relational, that integrates trauma treatment, and that wraps the practical supports of life — housing, childcare, health, legal help — around the clinical work rather than making a woman chase them across town.18 The relational, women-specific curricula developed by Stephanie Covington are among the most widely used expressions of this model and have supporting outcome studies, including in justice-involved populations.19 Integrated trauma-and-addiction therapies such as Seeking Safety are well studied and clearly help compared to usual care — though, to be accurate, they have not proven superior to other active treatments, and their effects are modest.20

The fragmentation problem

Here is what all of that runs up against in the real world. A woman in crisis in North Texas typically faces not one system but many, none of them talking to each other: an emergency shelter that can hold her for a few nights, a detox unit for a few days, an outpatient counseling slot across the county, a housing waitlist, a separate agency for food, another for her children. Each is doing its part. Together they hand her a part-time recovery assembled from pieces she has to transport herself between, on no sleep, with no car, while in crisis.

The evidence — and common sense — runs the other way. SAMHSA's women's-services guidance documents that comprehensive, integrated, “one-stop” delivery, in which the wraparound supports sit alongside the clinical care, is associated with better retention and better outcomes than fragmented services.18 A residential home that holds all of it under one roof, for long enough, is not a luxury version of help. For a woman with high needs and low resources, it is often the only version that works.

And the matter of faith

Mercy Manor is a Christ-centered home. Honesty requires that we tell you exactly what the research does and does not establish about that — because a great deal of what circulates on this subject does not survive scrutiny, and we would rather lose an argument than win it with a bad number.

What is defensible: in observational studies, greater religious involvement and spirituality are generally associated with lower substance use and, in some studies, better recovery outcomes.21 What is not established: that faith causes those better outcomes. Those studies cannot rule out that people already doing better are more likely to be religiously involved, and the controlled trials that could settle it — randomized tests of explicitly religious interventions — are few and show limited, inconsistent added benefit over secular care.22

And there is a finding that a faith-based home in particular must not ignore: the kind of faith matters. Research by Kenneth Pargament distinguishes positive religious coping — a secure sense of a loving God — from negative religious coping, or spiritual struggle, in which a person feels punished or abandoned by God. Positive coping is linked to better outcomes; spiritual struggle predicts worse ones.23 A woman arriving at Mercy Manor may be carrying exactly that struggle. Meeting it with grace rather than pressure is not only pastoral wisdom; it is what the evidence supports.

So we make no claim that faith is a clinical cure. We hold that a Christ-centered home offers something the research does gesture at — belonging, meaning, a community, and a source of hope — and we pair it, without apology, with trauma-informed clinical care and the other evidence on this page. Conviction and evidence are not in competition here.

What it costs, and what it returns

A year of residential care sounds expensive because it is a real investment. The research on return is worth stating carefully, because the figures are frequently mangled. The National Institute on Drug Abuse estimates that every $1 invested in addiction treatment yields roughly $4 to $7 in reduced drug-related crime and criminal-justice costs, and that when healthcare savings are added, total savings can exceed costs by about 12 to 1. Those are two different measures of two different things — crime-only, and crime-plus-health — and the underlying data are from the 1990s, so we cite them as indicative rather than current.24 The Oxford House trial's roughly $29,000 net societal benefit per person, discussed above, is a more recent and more direct measure, driven largely by reduced incarceration.8 Rigorous benefit-cost work by the Washington State Institute for Public Policy likewise finds that substance-use treatment programs generally return more than they cost, though the exact figure varies by program.25

Translated to Mercy Manor's own terms: it costs about $500 a month to house and support one woman. Against the documented public cost of her cycling through jail, emergency systems, and repeated short-term treatment, a year that ends in a stable, working, housed woman is not the expensive option. It is the economical one.

The honest limits of this evidence

A page like this is only trustworthy if it says plainly what it cannot prove. So, directly:

  • No study proves the number “twelve months.” The evidence supports “longer is better, with 90 days as a floor and diminishing certainty about the exact optimum.” A year is a reasoned choice within that evidence, not a figure a trial has validated. A meta-analysis has even found the empirical support for the “stay in treatment long enough” principle to be more mixed than its prominence suggests.26
  • Much of this is observational. Recovery capital, retention, and the faith associations come largely from studies that show relationships, not proof of cause. We have flagged that everywhere it applies rather than dressing correlation as causation.
  • The trauma-prevalence figures are ranges, not fixed facts, because different studies define trauma differently.
  • The faith evidence is genuinely limited, and we have said so rather than reaching for the inflated “success rates” some faith-based programs publish — figures that typically exclude everyone who dropped out and so cannot withstand review.

What survives all of those caveats is a convergence. Independent lines of research — chronic-illness medicine, treatment retention, recovery capital, the ACE studies, trauma-informed and gender-responsive care — point the same direction: a woman recovering from addiction, abuse, and instability does best with integrated, trauma-informed care, delivered in a stable place, for long enough to rebuild a life. No single study proves the model. The weight of the evidence recommends it.

Why Mercy Manor is built this way

Every design choice in the program traces to something on this page. A full year, because recovery is a chronic-condition problem and capital takes time to build. Residential and integrated, because fragmented care fails the women with the highest needs. Trauma-informed and for women specifically, because the wound underneath the addiction is usually older than the addiction. Faith at the center, held with grace rather than pressure, because that is our conviction and because the evidence rewards the secure kind of faith and warns against the coercive kind. And affordable to sustain, because a year that returns a woman to her own life is the economical mercy, not the expensive one.

That is why a year, and not thirty days.

If you or a woman you love needs this, start at Get Help or call 817-881-6613. If you want to make a year like this possible for one woman, that is what giving to Mercy Manor does.

Common questions

Why is a 30-day rehab often not enough?

Because addiction behaves like a chronic condition, not an acute one. A landmark 2000 review in JAMA showed that relapse rates for substance use disorder (40 to 60 percent a year) are similar to those for type 2 diabetes (30 to 50 percent) and hypertension and asthma (50 to 70 percent). No one treats diabetes with a single 28-day program and then withdraws all care. The National Institute on Drug Abuse states that treatment lasting less than 90 days is of limited effectiveness, and that the best outcomes come with longer durations and continuing care.

Does research prove a woman needs exactly one year?

No, and we will not claim it does. There is no randomized trial proving that twelve months is the single correct length. What the evidence does show is a consistent dose-response relationship — longer time in treatment is associated with better outcomes, 90 days is a widely cited minimum threshold rather than a target, and the resources that sustain recovery, such as stable housing, employment, and sober relationships, take many months to rebuild. A year is a reasoned response to that evidence, not a number proven by a single study.

What is recovery capital?

Recovery capital is a framework, developed by researchers Cloud and Granfield, describing the sum of resources a person can draw on to get and stay well: social capital (relationships and support), physical capital (housing, money, safety), human capital (health, skills, education), and cultural capital (values and belonging). Studies find that higher recovery capital predicts more sustained recovery. Because these resources have to be rebuilt over time, a longer residential stay is what gives a woman the time to accumulate them.

Why treat trauma and addiction together instead of separately?

Because for many women the substance use grew out of the trauma. A large majority of women in substance-use treatment have trauma histories, and a substantial share meet criteria for PTSD. Treating the addiction while leaving the underlying trauma unaddressed is associated with poorer retention and higher relapse. Federal guidance (SAMHSA) recommends integrated, trauma-informed, gender-responsive care that addresses both at once rather than sending a woman between separate systems.

Does faith actually help someone recover, according to research?

Honestly, the evidence is mixed and we will not overstate it. In observational studies, greater religious involvement and spirituality are generally associated with lower substance use and sometimes better recovery outcomes, but because those studies cannot rule out other explanations, they do not prove faith causes recovery. Controlled trials of explicitly religious interventions are few and show limited, inconsistent added benefit over secular treatment. Research also finds that the kind of faith matters: a secure, supportive relationship with God is linked to better outcomes, while spiritual struggle — feeling punished or abandoned by God — can predict worse ones. Mercy Manor is a Christ-centered home because of conviction and calling; we present the science as it actually stands.

References

  1. McLellan AT, Lewis DC, O'Brien CP, Kleber HD. “Drug Dependence, a Chronic Medical Illness: Implications for Treatment, Insurance, and Outcomes Evaluation.” JAMA. 2000;284(13):1689–1695. PubMed
  2. National Institute on Drug Abuse. Principles of Drug Addiction Treatment: A Research-Based Guide (3rd ed.), Principle 5. 2012 (updated). NIDA
  3. Simpson DD, Joe GW, Fletcher BW, Hubbard RL, Anglin MD. “A National Evaluation of Treatment Outcomes for Cocaine Dependence” (DATOS). Archives of General Psychiatry. 1999;56(6):507–514. PubMed
  4. Zhang Z, Friedmann PD, Gerstein DR. “Does Retention Matter? Treatment Duration and Improvement in Drug Use.” Addiction. 2003;98(5):673–684. PubMed
  5. Cloud W, Granfield R. “Conceptualizing Recovery Capital: Expansion of a Theoretical Construct.” Substance Use & Misuse. 2008;43(12–13):1971–1986. Publisher
  6. Laudet AB, White WL. “Recovery Capital as Prospective Predictor of Sustained Recovery, Life Satisfaction, and Stress Among Former Poly-Substance Users.” Substance Use & Misuse. 2008;43(1):27–54. PMC
  7. Jason LA, Olson BD, Ferrari JR, Lo Sasso AT. “Communal Housing Settings Enhance Substance Abuse Recovery.” American Journal of Public Health. 2006;96(10):1727–1729. PubMed
  8. Lo Sasso AT, Byro E, Jason LA, Ferrari JR, Olson B. “Benefits and Costs Associated with Mutual-Help Community-Based Recovery Homes: The Oxford House Model.” Evaluation and Program Planning. 2012;35(1):47–53. PubMed
  9. Reif S, George P, Braude L, et al. “Residential Treatment for Individuals With Substance Use Disorders: Assessing the Evidence.” Psychiatric Services. 2014;65(3):301–312. Publisher
  10. Substance Abuse and Mental Health Services Administration. Best Practices for Recovery Housing. Publication PEP23-10-00-002. 2023. SAMHSA
  11. Felitti VJ, Anda RF, Nordenberg D, et al. “Relationship of Childhood Abuse and Household Dysfunction to Many of the Leading Causes of Death in Adults: The Adverse Childhood Experiences (ACE) Study.” American Journal of Preventive Medicine. 1998;14(4):245–258. PubMed
  12. Dube SR, Felitti VJ, Dong M, Chapman DP, Giles WH, Anda RF. “Childhood Abuse, Neglect, and Household Dysfunction and the Risk of Illicit Drug Use.” Pediatrics. 2003;111(3):564–572. PubMed
  13. Shonkoff JP, Garner AS, et al. (American Academy of Pediatrics). “The Lifelong Effects of Early Childhood Adversity and Toxic Stress.” Pediatrics. 2012;129(1):e232–e246. Publisher
  14. Najavits LM, Weiss RD, Shaw SR. “The Link Between Substance Abuse and Posttraumatic Stress Disorder in Women: A Research Review.” American Journal on Addictions. 1997;6(4):273–283; and subsequent reviews. PubMed
  15. Kirst M, et al., and related reviews on the bidirectional relationship between intimate partner violence and substance use; see review in Frontiers in Psychology 2022;13:1028375. Frontiers
  16. Substance Abuse and Mental Health Services Administration. Substance Abuse Treatment: Addressing the Specific Needs of Women (TIP 51), Appendix on comprehensive/integrated services. 2009. NCBI Bookshelf
  17. Substance Abuse and Mental Health Services Administration. SAMHSA's Concept of Trauma and Guidance for a Trauma-Informed Approach. Publication SMA14-4884. 2014. SAMHSA
  18. Substance Abuse and Mental Health Services Administration. Substance Abuse Treatment: Addressing the Specific Needs of Women (TIP 51). 2009. NCBI Bookshelf
  19. Messina N, Calhoun S, Braithwaite J. “Trauma-Informed Treatment Decreases Posttraumatic Stress Disorder Among Women Offenders.” Journal of Trauma & Dissociation. 2014;15(1):6–23; Covington SS, gender-responsive curricula. CEBC
  20. Sherman ADF, et al. “Seeking Safety intervention for comorbid PTSD and substance use: a meta-analysis.” Brain and Behavior. 2023. PubMed
  21. Koenig HG. “Religion, Spirituality, and Health: The Research and Clinical Implications.” ISRN Psychiatry. 2012;2012:278730. PubMed
  22. Hai AH, Franklin C, et al. “The efficacy of spiritual/religious interventions for substance use problems: A systematic review and meta-analysis of randomized controlled trials.” Drug and Alcohol Dependence. 2019;202:134–148. PubMed
  23. Pargament KI, Koenig HG, Tarakeshwar N, Hahn J. “Religious Coping Methods as Predictors of Psychological, Physical and Spiritual Outcomes.” Journal of Health Psychology. 2004;9(6):713–730. Publisher
  24. National Institute on Drug Abuse. “Is drug addiction treatment worth its cost?” in Principles of Drug Addiction Treatment (3rd ed.). Underlying data include the CALDATA study (Gerstein et al., 1994). NIDA
  25. Washington State Institute for Public Policy. Benefit-Cost Results — Adult Behavioral Health / Substance Use Disorder program inventory (figures vary by program; updated periodically). WSIPP
  26. Pearson FS, et al. “Meta-analyses of seven of NIDA's principles of drug addiction treatment.” Journal of Substance Abuse Treatment. 2012. PMC

This page is educational and does not constitute medical advice. It describes population-level research; individual circumstances vary. Figures are current as of compilation and are dated to their sources; statistics are re-verified on our annual review cycle.